Table 1: Patient demographics and baseline ocular characteristics in the PRN and 3 monthly initial dose groups. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

BRVO: branch retinal vein occlusion; ELM: external limiting membrane; IS-OS: inner segment-outer segment; IT: inferior temporal; ST: superior temporal. value was obtained by student’s -test for continuous variables and chi-square or Fisher’s exact test for dichotomous variables. *Nonperfused area divided by the optic disc area ≥5. ^{†}Foveal nonperfusion was defined as the extent of capillary dropout on the fovea for >1 quadrant.^{‡}The area of retinal hemorrhage or capillary nonperfusion was measured in a circle with a radius of 3600 m centred on the fovea using Image software. By dividing this area by the area of the circle with a radius of 3600 m, the percentage of the area of retinal hemorrhage or capillary nonperfusion was calculated. |